248 related articles for article (PubMed ID: 33409878)
21. Combination of ovarian tissue harvesting and immature oocyte collection for fertility preservation increases preservation yield.
Hourvitz A; Yerushalmi GM; Maman E; Raanani H; Elizur S; Brengauz M; Orvieto R; Dor J; Meirow D
Reprod Biomed Online; 2015 Oct; 31(4):497-505. PubMed ID: 26278808
[TBL] [Abstract][Full Text] [Related]
22. Fertility preservation in women with malignancies: the accuracy of antral follicle count collected randomly during the menstrual cycle in predicting the number of oocytes retrieved.
Filippi F; Martinelli F; Paffoni A; Reschini M; Raspagliesi F; Somigliana E
J Assist Reprod Genet; 2019 Mar; 36(3):569-578. PubMed ID: 30478807
[TBL] [Abstract][Full Text] [Related]
23. Random start ovarian stimulation before gonadotoxic therapies in women with cancer: a systematic review and meta-analysis.
Sönmezer M; Şükür YE; Ateş C; Saçıntı KG; Sönmezer M; Aslan B; Atabekoğlu CS; Özmen B; Oktay KH
Reprod Biomed Online; 2023 Dec; 47(6):103337. PubMed ID: 37857156
[TBL] [Abstract][Full Text] [Related]
24. Effects of cancer stage and grade on fertility preservation outcome and ovarian stimulation response.
Volodarsky-Perel A; Cohen Y; Arab S; Son WY; Suarthana E; Dahan MH; Tulandi T; Buckett W
Hum Reprod; 2019 Mar; 34(3):530-538. PubMed ID: 30689898
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of random-start controlled ovarian stimulation in cancer patients.
Kim JH; Kim SK; Lee HJ; Lee JR; Jee BC; Suh CS; Kim SH
J Korean Med Sci; 2015 Mar; 30(3):290-5. PubMed ID: 25729252
[TBL] [Abstract][Full Text] [Related]
26. Ovarian stimulation is a safe and effective fertility preservation option in the adolescent and young adult population.
Manuel SL; Moravek MB; Confino R; Smith KN; Lawson AK; Klock SC; Pavone ME
J Assist Reprod Genet; 2020 Mar; 37(3):699-708. PubMed ID: 31828481
[TBL] [Abstract][Full Text] [Related]
27. Fertility preservation in female oncology patients: the influence of the type of cancer on ovarian stimulation response.
Alvarez RM; Ramanathan P
Hum Reprod; 2018 Nov; 33(11):2051-2059. PubMed ID: 27370358
[TBL] [Abstract][Full Text] [Related]
28. Ovarian stimulation for fertility preservation in patients with cancer.
Quintero RB; Helmer A; Huang JQ; Westphal LM
Fertil Steril; 2010 Feb; 93(3):865-8. PubMed ID: 19013563
[TBL] [Abstract][Full Text] [Related]
29. Random-start ovarian stimulation in patients with cancer.
Cakmak H; Rosen MP
Curr Opin Obstet Gynecol; 2015 Jun; 27(3):215-21. PubMed ID: 25919235
[TBL] [Abstract][Full Text] [Related]
30. Fertility preservation in female patients with hematological disorders.
Wu D; Shen H
BMC Pregnancy Childbirth; 2022 Jan; 22(1):61. PubMed ID: 35065646
[TBL] [Abstract][Full Text] [Related]
31. Reassessing the impact of letrozole co-administration in controlled ovarian hyperstimulation: findings from a single-center repeated measures study.
Jain NS; Licciardi F; Kalluru S; McCulloh DH; Blakemore JK
J Assist Reprod Genet; 2024 Apr; 41(4):979-987. PubMed ID: 38381391
[TBL] [Abstract][Full Text] [Related]
32. A simplified universal approach to COH protocol for IVF: ultrashort flare GnRH-agonist/GnRH-antagonist protocol with tailored mode and timing of final follicular maturation.
Orvieto R
J Ovarian Res; 2015 Nov; 8():69. PubMed ID: 26536862
[TBL] [Abstract][Full Text] [Related]
33. Usefulness of random-start progestin-primed ovarian stimulation for fertility preservation.
Huang H; Itaya Y; Samejima K; Ichinose S; Narita T; Matsunaga S; Saitoh M; Takai Y
J Ovarian Res; 2022 Jan; 15(1):2. PubMed ID: 34983605
[TBL] [Abstract][Full Text] [Related]
34. Random-start controlled ovarian hyperstimulation for emergency fertility preservation in letrozole cycles.
Sönmezer M; Türkçüoğlu I; Coşkun U; Oktay K
Fertil Steril; 2011 May; 95(6):2125.e9-11. PubMed ID: 21292255
[TBL] [Abstract][Full Text] [Related]
35. Optimizing human oocyte cryopreservation for fertility preservation patients: should we mature then freeze or freeze then mature?
Lee JA; Barritt J; Moschini RM; Slifkin RE; Copperman AB
Fertil Steril; 2013 Apr; 99(5):1356-62. PubMed ID: 23266213
[TBL] [Abstract][Full Text] [Related]
36. Female fertility preservation: Impact of cancer on ovarian function and oocyte quality.
Fabiani C; Ferrante MG; Meneghini C; Licata E; Paciotti G; Gallo M; Schiavi M; Spina V; Guarino A; Caserta D; Rago R
Int J Gynaecol Obstet; 2022 Jan; 156(1):166-171. PubMed ID: 33837528
[TBL] [Abstract][Full Text] [Related]
37. Fertility preservation with random-start controlled ovarian stimulation and embryo cryopreservation for early pregnancy-associated breast cancer.
Pereira N; Kligman I; Hunt R; Kopparam R; Wahmann B; Rosenwaks Z
Gynecol Endocrinol; 2019 Mar; 35(3):214-216. PubMed ID: 30403906
[TBL] [Abstract][Full Text] [Related]
38. Oocyte accumulation for fertility preservation in women with benign ovarian tumours with a history of previous surgery, multiple or large cysts.
Legrand C; Keller L; Collinet P; Barbotin AL; Béhal H; Rubod C; Decanter C
Reprod Biomed Online; 2021 Aug; 43(2):205-214. PubMed ID: 34247989
[TBL] [Abstract][Full Text] [Related]
39. Fertility preservation options in breast cancer patients.
Kasum M; von Wolff M; Franulić D; Čehić E; Klepac-Pulanić T; Orešković S; Juras J
Gynecol Endocrinol; 2015; 31(11):846-51. PubMed ID: 26370157
[TBL] [Abstract][Full Text] [Related]
40. Effects of letrozole or tamoxifen coadministered with a standard stimulation protocol on fertility preservation among breast cancer patients.
Shulman Y; Almog B; Kalma Y; Fouks Y; Azem F; Cohen Y
J Assist Reprod Genet; 2021 Mar; 38(3):743-750. PubMed ID: 33409757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]